Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Sahasthara Microemulsion** is an investigational topical microemulsion containing 1% ethanolic extract of Sahasthara, a Thai traditional multi-herb medicine comprising 21 botanical ingredients. It is being developed by Thammasat University as a locally applied anti-inflammatory and analgesic treatment for primary knee osteoarthritis. In the completed randomized double-blind Phase 2 study NCT06184685, the product was applied to the affected knee at 2 mL three times daily for 28 days and was compared with 2% diclofenac microemulsion. Sahasthara extract has shown anti-inflammatory and antioxidant activity in preclinical studies, including inhibition of inflammatory nitric oxide and prostaglandin E2 production, but no single validated molecular target has been established for the complete botanical formulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sahasthara Microemulsion.